Flaharty Asset Management’s Abiomed Inc ABMD Stock Holding History

Flaharty Asset Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,300	Closed	-$314K	–	72
2020 Q2	$314K	Buy	+1,300	New	+$261K	0.11%	56
2020 Q1	–	Sell	-1,300	Closed	-$222K	–	77
2019 Q4	$222K	Hold	1,300	–	–	0.08%	67
2019 Q3	$231K	Hold	1,300	–	–	0.09%	64
2019 Q2	$339K	Hold	1,300	–	–	0.13%	56
2019 Q1	$371K	Hold	1,300	–	–	0.15%	57
2018 Q4	$423K	Hold	1,300	–	–	0.18%	47
2018 Q3	$578K	Hold	1,300	–	–	0.22%	37
2018 Q2	$532K	Sell	1,300 -31	-2%	-$11.2K	0.21%	37
2018 Q1	$371K	Hold	1,331	–	–	0.16%	68
2017 Q4	$277K	Buy	1,331 +31	+2%	+$5.79K	0.12%	78
2017 Q3	$226K	Buy	+1,300	New	+$197K	0.12%	55

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Flaharty Asset Management's ABMD Position: Q3 2020 in Review

Flaharty Asset Management sold out of Abiomed Inc (ABMD) in Q3 2020, closing a stake of 1,300 shares — an estimated $314K sold.

Flaharty Asset Management first reported a position in ABMD in Q3 2017 and held it in 11 quarters. The position peaked at $578K in Q3 2018. 498 funds tracked by Wall St. Rank hold ABMD as of Q3 2020.

Flaharty Asset Management reported no remaining Abiomed Inc position as of Q3 2020 after selling out during the quarter.
Flaharty Asset Management sold 1,300 Abiomed Inc shares in Q3 2020, an estimated $314K.
Flaharty Asset Management first reported a position in Abiomed Inc in Q3 2017 and held it in 11 quarters.
Flaharty Asset Management's Abiomed Inc position peaked at $578K in Q3 2018.
498 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2020.

Based on Flaharty Asset Management's 13F filing for Q3 2020, filed 12 Nov 2020.